DarioHealth (DRIO) Free Cash Flow (2012 - 2026)

DarioHealth (DRIO) has reported Free Cash Flow for 15 consecutive years, with -$6.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow fell 0.76% year-over-year to -$6.1 million; the trailing twelve-month figure through Jun 2026 stood at -$25.5 million (up 5.35% YoY), and the FY2025 full-year result was -$26.1 million, up 32.6% from the prior year.
• Free Cash Flow eased to -$6.1 million in Q2 2026 per DRIO's latest filing, from -$6.1 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$4.8 million in Q1 2023 and bottomed at -$18.2 million in Q1 2022.
• Historically, Free Cash Flow has averaged -$8.7 million across 5 years, with a median of -$7.4 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Free Cash Flow jumped 73.4% in 2023, then tumbled 172.53% in 2024.
• Over 5 years, Free Cash Flow stood at -$8.0 million in 2022, then increased by 7.01% to -$7.4 million in 2023, then rose by 9.04% to -$6.8 million in 2024, then grew by 12.44% to -$5.9 million in 2025, then dropped by 3.52% to -$6.1 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$6.1 million, -$6.1 million, and -$5.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.